Investbanq Insider: November, 2025

Investbanq Insider: November, 2025

10 Defensive Stocks with Market-Beating Yields

As market volatility rises and investor sentiment cools, shifting toward defensive sectors may offer stability — and attractive returns.

After a strong year for equities, recent turbulence has reminded investors that bull markets rarely move in straight lines. Over the past week, the S&P 500 slid about 1.6%, marking its sharpest weekly drop in more than a month. The tech-heavy Nasdaq Composite fared worse, tumbling 3% — its steepest decline since April — as concerns mounted over overheated valuations and fading momentum in growth stocks.

Adding to the unease, a wave of corporate layoffs and weaker consumer sentiment data have cast doubt on the resilience of U.S. economic growth. Against this backdrop, investors are re-evaluating portfolio risk and seeking companies with reliable earnings, sustainable dividends, and steady demand — qualities typically found in defensive sectors such as consumer staples, utilities, and healthcare.

###How the Screen Was Built

To identify resilient opportunities, we are using FactSet data, screened for large-cap companies across defensive industries that combine earnings growth, dividend income, and financial discipline.

  • Earnings growth: Analysts expect at least 5% operating-profit growth over the next 12 months — slower than the overall market but comfortably above inflation, signaling underlying strength.
  • Dividends: All selected companies yield above the S&P 500’s modest 1%, with many offering double that.
  • Payout ratio: Dividends consume no more than 60% of net income, ensuring that distributions are sustainable even in a downturn.

Top Picks: Stability with Yield

Leading the list is AES Corp. (AES), a renewable-energy producer offering a 5.4% yield and 12% expected earnings growth. Despite headwinds from U.S. policy shifts on clean-energy credits — and takeover speculation that AES declined to address — the company’s valuation looks compelling, trading at just 6.2 times forward earnings.

Other strong contenders include discount retailer Dollar General (DG) and grocer Kroger (KR), both of which tend to outperform when consumers tighten budgets. In healthcare, Merck (MRK) and Abbott Laboratories (ABT) stand out for combining consistent dividend growth with solid profit expansion of 16% and 10%, respectively.

Utilities — long favored for their predictability — also feature prominently, with CenterPoint Energy (CNP), American Water Works (AWK), and Atmos Energy (ATO) all offering stable earnings growth between 8–11% and dependable yields around 2.5%.

Rounding out the list, Sanofi (SAN) and UnitedHealth Group (UNH) provide exposure to healthcare services with high dividend yields.

image Source: FactSet

Investor Takeaways

Periods of heightened volatility often remind investors of the importance of balance. While growth stocks may lead during expansions, defensive companies with healthy dividends and strong cash flows can provide critical ballast when sentiment turns cautious. With yields far above the S&P 500 average and consistent earnings momentum, the names on this list offer investors both income resilience and downside protection. In the months ahead, as macro uncertainty persists and rates remain elevated, leaning toward quality and defense may prove the most strategic way to preserve gains from the market’s earlier rally.

Disclaimer

Information contained in this material is obtained from sources believed to be reliable, however, there is neither representation, warranty nor guarantee, in any manner that accuracy, completeness, timeliness, reliability or suitability expressed or implied for any purpose that users of the material may be intended. Users or any third parties acknowledge that Investbanq Pte. Ltd. (“Paladigm”), its information providers or any related licensors or employees shall not be held liable for or to any contractual, tortuous liability, damage or consequence including but not limited to lost opportunity in connection with the use of the information in any way claimed to be arising.

Paladigm may discontinue or make changes in the information, products or services in this material at any time without prior notice to users.

No solicitation or offer of any investment instruments or services in any jurisdiction shall be constructed.

Information including but not limited to financial data, commentary or any other materials contained in the material is the properties of Paladigm, unless written consent from Paladigm is obtained, no information may, in any manner, be copied, transmitted, disseminated, sold, distributed, published, broadcasted, circulated for any purpose, cause or reason.

Materials related to certain investment tools of which authorization has not been obtained is not intended to, and shall not, be distributed or circulated publicly. Readers acknowledge that access to those materials is taken on readers' own initiative.

There can be no assurance that the investment objectives of any program, products or services will be met. Past performance is not necessarily indicative of future results. Futures and options trading involves substantial risk of loss. An investor could potentially lose more than the initial investment. Investor must read current agreements and any applicable supplements before they invest.

Contact us

Leave your contact details and our manager will be in touch as soon as possible to provide advice on any questions you may have.

By sending this request you consent to the processing and storage of your personal data according to Privacy Policy.